MT-2004

N/A

Report date: 2023/09/01 20:00:50
NME

Base Information

Drug NameMT-2004
Drug Alias NameMT-2004胶囊MT-2004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsHepatic InsufficiencyMetabolic Dysfunction-Associated Steatotic Liver DiseaseChemical and Drug Induced Liver Injury +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXi'An Aolitai Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesXi'An Biocare Pharma LtdShaanxi Micot Pharmaceutical Technology Co LtdXi'An Aolitai Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatic InsufficiencyMetabolic Dysfunction-Associated Steatotic Liver DiseaseChemical and Drug Induced Liver Injury +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A